2020 Was The Year of Psychedelics — Here's Why

Financial world news, market analysis, investment scam prevention tips and more ✔️ Learn all there is to know about the asset management industry. This magazine is crafted specifically for those who are interested in diving into the global asset management world. While many 2020 memories will be gladly left behind, that's not necessarily the case for psychedelics.There was unprecedented renaissance as psychedelic compounds, and their potential to treat mental health conditions, became one of the centerpieces of this year’s public conversation.  Psychedelic companies — those researching and producing these compounds — jumped into the spotlight of investment markets, with almost two dozen psychedelics companies going public between February and December. A public, institutional and financial interest in psychedelics ushered in a series of regulatory and legislative measures that opened the floodgates to levels of research never before seen in the space. The impressive amount of news related to this sector also prompted Benzinga to launch Psyched, a weekly column on psychedelics which has already reached 30 issues and thousands of readers. Psychedelics Companies Go Public MindMed (NEO:MMED) (OTCQB:MMEDF) became the first pure-play psychedelics company to IPO in a public exchange in Canada, debuting at the NEO exchange on March 3. Since then, at least 20 more companies hit the public exchanges. Canada’s fitting environment for small-cap venture investment, laid down by the mining sector, established the perfect runway for psychedelics companies to debut in the public markets, following the steps that cannabis took back To keep reading about 2020 Was The Year of Psychedelics — Here's Why, Click on the link. Seoul, Korea
http://dlvr.it/RpTcmf